Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Behav Immun ; 60: 15-26, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27524669

ABSTRACT

Ischemic stroke elicits a prompt inflammatory response that is characterized by a well-timed recruitment of peripheral immune cells to the brain. Among these, monocytes play a particularly important, but multifaceted role and have been increasingly recognized to affect stroke outcome. Granulocyte colony stimulating factor (GCSF) is known for its immunosuppressive actions on mononuclear cells, but previous studies in the stroke field were mainly confined to its neuroprotective actions. Herein, we investigated whether GCSF affects post-stroke inflammation in a mouse model of focal brain ischemia by modulating monocyte responses. Treatment with GCSF was controlled by vehicle injection, sham surgery and naive animals. Despite a significant monocytosis, high-dosage GCSF reduced the number of brain-infiltrating monocytes/macrophages four days after stroke. Lower numbers of mononuclear phagocytes in the brain were associated with smaller cerebral edema and improved motor outcome after stroke. GCSF treatment over 72h, but not 24h diminished integrin expression on circulating Ly6C+ inflammatory monocytes. In vitro experiments further revealed that GCSF strongly promotes interleukin (IL)-10 secretion by activated mononuclear cells. Blockade of the IL-10 receptor partly reversed GCSF-induced downregulation of integrin surface expression. Overall, our results suggest that high-dosage GCSF mitigates monocyte infiltration after stroke, likely by attenuating integrin-mediated adhesion to the brain endothelium in an IL-10-dependent manner. Lower amounts of mononuclear cells in the brain translate to less severe brain edema and functional impairment and thus support a harmful role of Ly6C+ inflammatory monocytes in the acute stage of stroke.


Subject(s)
Brain Ischemia/drug therapy , Brain/drug effects , Cell Movement/drug effects , Granulocyte Colony-Stimulating Factor/pharmacology , Monocytes/drug effects , Animals , Brain/metabolism , Brain Edema/drug therapy , Brain Ischemia/metabolism , Disease Models, Animal , Granulocyte Colony-Stimulating Factor/administration & dosage , Inflammation/drug therapy , Inflammation/metabolism , Male , Mice, Inbred C57BL , Monocytes/metabolism
2.
J Vis Exp ; (108): 53658, 2016 Feb 12.
Article in English | MEDLINE | ID: mdl-26967380

ABSTRACT

Ischemic stroke initiates a robust inflammatory response that starts in the intravascular compartment and involves rapid activation of brain resident cells. A key mechanism of this inflammatory response is the migration of circulating immune cells to the ischemic brain facilitated by chemokine release and increased endothelial adhesion molecule expression. Brain-invading leukocytes are well-known contributing to early-stage secondary ischemic injury, but their significance for the termination of inflammation and later brain repair has only recently been noticed. Here, a simple protocol for the efficient isolation of immune cells from the ischemic mouse brain is provided. After transcardial perfusion, brain hemispheres are dissected and mechanically dissociated. Enzymatic digestion with Liberase is followed by density gradient (such as Percoll) centrifugation to remove myelin and cell debris. One major advantage of this protocol is the single-layer density gradient procedure which does not require time-consuming preparation of gradients and can be reliably performed. The approach yields highly reproducible cell counts per brain hemisphere and allows for measuring several flow cytometry panels in one biological replicate. Phenotypic characterization and quantification of brain-invading leukocytes after experimental stroke may contribute to a better understanding of their multifaceted roles in ischemic injury and repair.


Subject(s)
Infarction, Middle Cerebral Artery/pathology , Leukocytes/immunology , Animals , Brain/immunology , Brain/pathology , Cell Count , Cell Separation/methods , Centrifugation, Density Gradient , Disease Models, Animal , Dissection/methods , Encephalitis/immunology , Encephalitis/pathology , Flow Cytometry/methods , Infarction, Middle Cerebral Artery/immunology , Male , Mice, Inbred C57BL , Microglia/immunology , Microglia/pathology , Myelin Sheath/immunology , Stroke/immunology , Stroke/pathology , Suture Techniques
3.
Front Cell Neurosci ; 9: 461, 2015.
Article in English | MEDLINE | ID: mdl-26640428

ABSTRACT

Arterial hypertension is not only the leading risk factor for stroke, but also attributes to impaired recovery and poor outcome. The latter could be explained by hypertensive vascular remodeling that aggravates perfusion deficits and blood-brain barrier disruption. However, besides vascular changes, one could hypothesize that activation of the immune system due to pre-existing hypertension may negatively influence post-stroke inflammation and thus stroke outcome. To test this hypothesis, male adult spontaneously hypertensive rats (SHRs) and normotensive Wistar Kyoto rats (WKYs) were subjected to photothrombotic stroke. One and 3 days after stroke, infarct volume and functional deficits were evaluated by magnetic resonance imaging and behavioral tests. Expression levels of adhesion molecules and chemokines along with the post-stroke inflammatory response were analyzed by flow cytometry, quantitative real-time PCR and immunohistochemistry in rat brains 4 days after stroke. Although comparable at day 1, lesion volumes were significantly larger in SHR at day 3. The infarct volume showed a strong correlation with the amount of CD45 highly positive leukocytes present in the ischemic hemispheres. Functional deficits were comparable between SHR and WKY. Brain endothelial expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and P-selectin (CD62P) was neither increased by hypertension nor by stroke. However, in SHR, brain infiltrating myeloid leukocytes showed significantly higher surface expression of ICAM-1 which may augment leukocyte transmigration by leukocyte-leukocyte interactions. The expression of chemokines that primarily attract monocytes and granulocytes was significantly increased by stroke and, furthermore, by hypertension. Accordingly, ischemic hemispheres of SHR contain considerably higher numbers of monocytes, macrophages and granulocytes. Exacerbated brain inflammation in SHR may finally be responsible for larger infarct volumes. These findings provide an immunological explanation for the epidemiological observation that existing hypertension negatively affects stroke outcome and mortality.

4.
Curr Neurovasc Res ; 12(2): 155-62, 2015.
Article in English | MEDLINE | ID: mdl-25760217

ABSTRACT

Ischemic stroke swiftly induces a wide spectrum of pathophysiological sequelae, particularly in the aged brain. The translational failure of experimental therapies, might partially be related to monotherapeutic approaches, not address potential counter-mechanisms sufficiently or within the best time window. For example, therapeutic effects relying on stem/progenitor cell mobilization by granulocyte-colony stimulating factor (G-CSF), require approximately a week to become manifest, which is potentially beyond the optimal timing. Here, We tested the hypothesis that treating post-stroke aged rats with the combination of bone marrow-derived mononuclear cells (BM MNC) and G-CSF improves the long term (56 days) functional outcome by compensating the delay before G-CSF effects come to full effect. 1x10(6) syngeneic BM MNC per kg bodyweight (BW) with G-CSF (50 µg/kg, given intraperitoneal by via the jugular vein to aged Sprague- Dawley rats, six hours post-stroke. This process was repeated daily, for a 28 day period. Infarct volume was measured by magnetic resonance imaging at 3 and 48 days post-stroke and additionally by immunohistochemistry at day 56. Functional recovery was tested during the entire post-stroke survival period. Daily G-CSF treatment led to a robust and consistent improvement of neurological function, but did not alter final infarct volumes. The combination of G-CSF and BM MNC, did not further improve post-stroke recovery. The lack of an additional benefit may be due to interaction between both approaches, and to a lesser extent, in the insensitivity of the aged brains' regenerative mechanisms. Also considering recent findings on other tandem approaches involving G-CSF in animal models featuring relevant co-morbidities, we conclude that such combination therapies are not the optimal approach to treat the acutely injured aged brain.


Subject(s)
Bone Marrow Transplantation/methods , Granulocyte Colony-Stimulating Factor/administration & dosage , Leukocytes, Mononuclear/transplantation , Stroke/therapy , Aging , Animals , Brain/pathology , Combined Modality Therapy , Disease Models, Animal , Male , Rats , Rats, Sprague-Dawley , Recovery of Function , Stroke/pathology
5.
Acta Neuropathol Commun ; 2: 169, 2014 Dec 18.
Article in English | MEDLINE | ID: mdl-25519173

ABSTRACT

INTRODUCTION: Cerebral small vessel disease (cSVD) is one of the most prevalent neurological disorders. The progressive remodeling of brain microvessels due to arterial hypertension or other vascular risk factors causes subtle, but constant cognitive decline through to manifest dementia and substantially increases the risk for stroke. Preliminary evidence suggests the contribution of the immune system to disease initiation and progression, but a more detailed understanding is impaired by the unavailability of appropriate animal models. Here, we introduce the spontaneously hypertensive rat (SHR) as a model for early onset cSVD and unveiled substantial immune changes in conjunction with brain abnormalities that resemble clinical findings. RESULTS: In contrast to age-matched normotensive Wistar Kyoto (WKY) rats, male SHR exhibited non-spatial memory deficits. Magnetic resonance imaging showed brain atrophy and a reduction of white matter volumes in SHR. Histological analyses confirmed white matter demyelination and unveiled a circumscribed blood brain barrier dysfunction in conjunction with micro- and macrogliosis in deep cortical regions. Flow cytometry and histological analyses further revealed substantial disparities in cerebral CD45high leukocyte counts and distribution patterns between SHR and WKY. SHR showed lower counts of T cells in the choroid plexus and meningeal spaces as well as decreased interleukin-10 levels in the cerebrospinal fluid. On the other hand, both T and NK cells were significantly augmented in the SHR brain microvasculature. CONCLUSIONS: Our results indicate that SHR share behavioral and neuropathological characteristics with human cSVD patients and further undergird the relevance of immune responses for the initiation and progression of cSVD.


Subject(s)
Brain/pathology , Cerebral Small Vessel Diseases/physiopathology , Cognition Disorders/physiopathology , Disease Models, Animal , Neuroimmunomodulation/physiology , White Matter/pathology , Animals , Atrophy , Blood-Brain Barrier/physiopathology , Brain/physiopathology , Cerebral Small Vessel Diseases/pathology , Cerebral Small Vessel Diseases/psychology , Cognition Disorders/pathology , Gliosis/immunology , Gliosis/pathology , Interleukin-10/cerebrospinal fluid , Killer Cells, Natural/pathology , Killer Cells, Natural/physiology , Leukocyte Common Antigens/metabolism , Leukocytes/pathology , Leukocytes/physiology , Male , Memory Disorders/immunology , Memory Disorders/pathology , Organ Size , Random Allocation , Rats, Inbred SHR , Rats, Inbred WKY , T-Lymphocytes/pathology , T-Lymphocytes/physiology , White Matter/physiopathology
6.
Stroke ; 45(2): 623-6, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24407949

ABSTRACT

BACKGROUND AND PURPOSE: Granulocyte colony-stimulating factor (GCSF) showed robust neuroprotective and neuroregenerative properties after stroke in rodents but failed to meet study end points in patients. Because immunologic side effects of GCSF may have escaped preclinical testing because of nonallometric dose translation, we hypothesized those as possible reasons. METHODS: Stroke was induced in C57BL/6 mice by 45-minute filament middle cerebral artery occlusion. GCSF was administered at 50 and 832.5 µg/kg body weight. Treatment was controlled by vehicle injection, sham surgery, and naive animals. Immune cell counts were assessed in blood, spleen, and brain by multidimensional flow cytometry 1 day after stroke. RESULTS: High-dose GCSF significantly altered myeloid and T-cell subpopulations in blood and spleen and caused a tremendous increase of monocytes/macrophages infiltrating the ischemic brain. CONCLUSIONS: Dose-dependent immunomodulation superimposes central nervous system-specific effects of GCSF after stroke. Adaption of dose or treatment time may overcome this drawback.


Subject(s)
Granulocyte Colony-Stimulating Factor/therapeutic use , Stroke/drug therapy , Stroke/immunology , Animals , Brain/immunology , Brain/pathology , Central Nervous System/immunology , Central Nervous System/pathology , Dose-Response Relationship, Drug , Flow Cytometry , Granulocyte Colony-Stimulating Factor/adverse effects , Immunomodulation , Infarction, Middle Cerebral Artery/pathology , Inflammation/etiology , Male , Mice , Mice, Inbred C57BL , Neutrophil Infiltration , Peripheral Nerves/immunology , Peripheral Nerves/pathology , Spleen/cytology , Spleen/pathology , Stroke/complications , T-Lymphocytes/immunology , Treatment Outcome
7.
J Cereb Blood Flow Metab ; 34(2): 307-15, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24220169

ABSTRACT

The pathophysiology of stroke is governed by immune reactions within and remote from the injured brain. Hypertension, a major cause and comorbidity of stroke, entails systemic vascular inflammation and may influence poststroke immune responses. This aspect is, however, underestimated in previous studies. Here we aimed to delineate the sequence of cellular inflammation after stroke in spontaneously hypertensive (SH) rats. Spontaneously hypertensive rats were subjected to permanent middle cerebral artery occlusion and killed after 1 or 4 days. Immune cells of the peripheral blood and those which have infiltrated the injured brain were identified and quantified by flow cytometry. The spatial distribution of myeloid cells and T lymphocytes, and the infarct volume were assessed by histology. We observed a concerted infiltration of immune cells into the ischemic brain of SH rats. At day 1, primarily neutrophils, monocytes, macrophages, and myeloid dendritic cells entered the brain, whereas the situation at day 4 was dominated by microglia, macrophages, lymphatic dendritic cells, and T cells. Postischemic inflammation did not cause secondary tissue damage during the subacute stage of experimental stroke in SH rats. Considering the intrinsic vascular pathology of SH rats, our study validates this strain for further translational research in poststroke inflammation.


Subject(s)
Brain/pathology , Dendritic Cells/pathology , Hypertension/pathology , Infarction, Middle Cerebral Artery/pathology , Leukocytes/pathology , Microglia/pathology , Animals , Brain/blood supply , Brain/metabolism , Brain/physiopathology , Dendritic Cells/metabolism , Hypertension/metabolism , Hypertension/physiopathology , Infarction, Middle Cerebral Artery/complications , Infarction, Middle Cerebral Artery/metabolism , Infarction, Middle Cerebral Artery/physiopathology , Inflammation/etiology , Inflammation/metabolism , Inflammation/pathology , Inflammation/physiopathology , Leukocytes/metabolism , Microglia/metabolism , Rats , Rats, Inbred SHR
8.
PLoS One ; 7(12): e50293, 2012.
Article in English | MEDLINE | ID: mdl-23236366

ABSTRACT

Bone marrow mononuclear cells (BMNCs) are widely used in regenerative medicine, but recent data suggests that the isolation of BMNCs by commonly used Ficoll-Paque density gradient centrifugation (DGC) causes significant cell loss and influences graft function. The objective of this study was to determine in an animal study whether and how Ficoll-Paque DGC affects the yield and composition of BMNCs compared to alternative isolation methods such as adjusted Percoll DGC or immunomagnetic separation of polymorphonuclear cells (PMNs). Each isolation procedure was confounded by a significant loss of BMNCs that was maximal after Ficoll-Paque DGC, moderate after adjusted Percoll DGC and least after immunomagnetic PMN depletion (25.6±5.8%, 51.5±2.3 and 72.3±6.7% recovery of total BMNCs in lysed bone marrow). Interestingly, proportions of BMNC subpopulations resembled those of lysed bone marrow indicating symmetric BMNC loss independent from the isolation protocol. Hematopoietic stem cell (HSC) content, determined by colony-forming units for granulocytes-macrophages (CFU-GM), was significantly reduced after Ficoll-Paque DGC compared to Percoll DGC and immunomagnetic PMN depletion. Finally, in a proof-of-concept study, we successfully applied the protocol for BMNC isolation by immunodepletion to fresh human bone marrow aspirates. Our findings indicate that the common method to isolate BMNCs in both preclinical and clinical research can be considerably improved by replacing Ficoll-Paque DGC with adapted Percoll DGC, or particularly by immunodepletion of PMNs.


Subject(s)
Bone Marrow Cells/cytology , Cell Separation/methods , Centrifugation, Density Gradient/methods , Hematopoietic Stem Cells/cytology , Humans
9.
Exp Transl Stroke Med ; 4(1): 20, 2012 Oct 02.
Article in English | MEDLINE | ID: mdl-23031714

ABSTRACT

The pathophysiology of sterile inflammation following focal ischemic stroke is complex and not fully understood, but there is growing evidence that it offers several therapeutic options beyond the hitherto existing treatment strategies. The identification and quantification of infiltrating inflammatory cells in animal models of stroke is crucial both for understanding post-stroke inflammation and for drug target identification. Multicolor flow cytometry plays an important role in determining subtypes and quantity of leukocytes that infiltrate the brain tissue after stroke. Until now, most investigations have been performed in mice, most likely due to a significantly broader spectrum of disposable antibodies and available knockout models. Here, we introduce a specific and reproducible method to isolate leukocytes from rat brain specimen in the context of brain ischemia to ultimately allow multi-dimensional flow cytometric characterization and further downstream methods such as cell-subtype sorting and molecular biological approaches.

SELECTION OF CITATIONS
SEARCH DETAIL
...